Pacific Edge to stay in trading halt while legal team assesses proposal

Pacific Edge to stay in trading halt while legal team assesses proposal
Dan Brunskill
Pacific Edge will stay in a trading halt while its legal team looks at a draft proposal that could change whether its cancer test is eligible for health insurance funding. The company asked the exchange to stop trading this morning after it became aware its Cxbladder product was mentioned in a draft proposal from healthcare provider Novitas. Novitas provides government-sponsored healthcare in 11 US states and Washington DC, under the Medicare program.Cxbladder is currently eligible for reimbursement, meaning Novitas covers the cost of...